dc.creatorVictor, Jefferson R
dc.creatorMuniz, Bruno P
dc.creatorFusaro, Ana E
dc.creatorde Brito, Cyro A
dc.creatorTaniguchi, Eliana F
dc.creatorDuarte, Alberto JS
dc.creatorSato, Maria N
dc.date.accessioned2013-08-26T16:58:20Z
dc.date.accessioned2018-07-04T16:27:05Z
dc.date.available2013-08-26T16:58:20Z
dc.date.available2018-07-04T16:27:05Z
dc.date.created2013-08-26T16:58:20Z
dc.date.issued2010
dc.identifierBMC Immunology. 2010 Mar 11;11(1):11
dc.identifier1471-2172
dc.identifierhttp://www.producao.usp.br/handle/BDPI/32795
dc.identifier10.1186/1471-2172-11-11
dc.identifierhttp://www.biomedcentral.com/1471-2172/11/11
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1635947
dc.description.abstractAbstract Background Preconception allergen immunization prevents neonatal allergen sensitization in mice by a complex interaction between regulatory cells/factors and antibodies. The present study assessed the influence of maternal immunization with ovalbumin (OVA) on the immune response of 3 day-old and 3 week-old offspring immunized or non-immunized with OVA and evaluated the effect of IgG treatment during fetal development or neonatal period. Results Maternal immunization with OVA showed increased levels of FcγRIIb expression in splenic B cells of neonates, which were maintained for up to 3 weeks and not affected by additional postnatal OVA immunization. Maternal immunization also exerted a down-modulatory effect on both IL-4 and IFN-γ-secreting T cells and IL-4 and IL-12- secreting B cells. Furthermore, immunized neonates from immunized mothers showed a marked inhibition of antigen-specifc IgE Ab production and lowered Th2/Th1 cytokine levels, whereas displaying enhanced FcγRIIb expression on B cells. These offspring also showed reduced antigen-specific proliferative response and lowered B cell responsiveness. Moreover, in vitro evaluation revealed an impairment of B cell activation upon engagement of B cell antigen receptor by IgG from OVA-immunized mice. Finally, in vivo IgG transference during pregnancy or breastfeeding revealed that maternal Ab transference was able to increase regulatory cytokines, such as IL-10, in the prenatal stage; yet only the postnatal treatment prevented neonatal sensitization. None of the IgG treatments induced immunological changes in the offspring, as it was observed for those from OVA-immunized mothers. Conclusion Maternal immunization upregulates the inhibitory FcγRIIb expression on offspring B cells, avoiding skewed Th2 response and development of allergy. These findings contribute to the advancement of prophylactic strategies to prevent allergic diseases in early life.
dc.languageeng
dc.relationBMC Immunology
dc.rightsVictor et al; licensee BioMed Central Ltd. - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.rightsopenAccess
dc.titleMaternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución